Ainos Price to Book Ratio 2012-2026 | AIMD
Historical price to book ratio values for Ainos (AIMD) over the last 10 years. The current price to book ratio for Ainos as of September 15, 2026 is 3.56.
| Ainos Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-09-15 | 1.37 | 3.08 | |
| 2026-06-30 | 1.94 | $0.44 | 4.36 |
| 2026-03-31 | 1.39 | $0.93 | 1.49 |
| 2025-12-31 | 1.64 | $1.30 | 1.26 |
| 2025-09-30 | 3.47 | $2.09 | 1.66 |
| 2025-06-30 | 2.83 | $2.68 | 1.06 |
| 2025-03-31 | 2.46 | $3.81 | 0.64 |
| 2024-12-31 | 2.28 | $5.03 | 0.45 |
| 2024-09-30 | 2.40 | $6.52 | 0.37 |
| 2024-06-30 | 4.07 | $14.02 | 0.29 |
| 2024-03-31 | 5.70 | $18.45 | 0.31 |
| 2023-12-31 | 10.25 | $26.13 | 0.39 |
| 2023-09-30 | 15.50 | $34.10 | 0.45 |
| 2023-06-30 | 17.00 | $37.45 | 0.45 |
| 2023-03-31 | 21.75 | $40.40 | 0.54 |
| 2022-12-31 | 15.50 | $43.26 | 0.36 |
| 2022-09-30 | 47.25 | $46.75 | 1.01 |
| 2022-06-30 | 108.75 | $1.04 | 104.57 |
| 2022-03-31 | 198.75 | $20.98 | 9.47 |
| 2021-12-31 | 315.00 | $26.49 | 11.89 |
| 2021-09-30 | 276.75 | $45.09 | 6.14 |
| 2021-06-30 | 360.00 | $47.96 | 7.51 |
| 2021-03-31 | 198.38 | $-11.39 | -17.42 |
| 2020-12-31 | 0.17 | $-7.47 | -0.02 |
| 2020-09-30 | 0.21 | $-7.11 | -0.03 |
| 2020-06-30 | 0.23 | $-4.98 | -0.05 |
| 2020-03-31 | 0.26 | $-4.01 | -0.07 |
| 2019-12-31 | 0.30 | $-1.45 | -0.21 |
| 2019-09-30 | 0.40 | $0.74 | 0.54 |
| 2019-06-30 | 0.36 | $2.26 | 0.16 |
| 2019-03-31 | 0.44 | $5.23 | 0.08 |
| 2018-12-31 | 0.27 | $7.00 | 0.04 |
| 2018-09-30 | 0.34 | $8.14 | 0.04 |
| 2018-06-30 | 0.28 | $6.98 | 0.04 |
| 2018-03-31 | 0.20 | $8.67 | 0.02 |
| 2017-12-31 | 0.28 | $7.62 | 0.04 |
| 2017-09-30 | 0.27 | $-15.89 | -0.02 |
| 2017-06-30 | 0.29 | $-14.56 | -0.02 |
| 2017-03-31 | 0.23 | $-15.19 | -0.02 |
| 2016-12-31 | 0.27 | $-13.85 | -0.02 |
| 2016-09-30 | 0.30 | $-8.54 | -0.04 |
| 2016-06-30 | 0.13 | $-5.40 | -0.02 |
| 2016-03-31 | 0.18 | $-6.39 | -0.03 |
| 2015-12-31 | 0.16 | $-8.78 | -0.02 |
| 2015-09-30 | 0.16 | $-5.20 | -0.03 |
| 2015-06-30 | 0.30 | $-4.57 | -0.07 |
| 2015-03-31 | 0.21 | $-2.66 | -0.08 |
| 2014-12-31 | 0.41 | $-0.57 | -0.72 |
| 2014-09-30 | 0.04 | $-512.70 | 0.00 |
| 2014-06-30 | 41.32 | $-501.77 | -0.08 |
| 2014-03-31 | 0.15 | $-482.81 | 0.00 |
| 2013-12-31 | 0.02 | $-24.46 | 0.00 |
| 2013-09-30 | 0.34 | $-451.83 | 0.00 |
| 2013-06-30 | 0.02 | $-438.19 | 0.00 |
| 2013-03-31 | 0.27 | $-418.69 | 0.00 |
| 2012-12-31 | 0.29 | $-399.84 | 0.00 |
| 2012-09-30 | 92.62 | $-398.42 | -0.23 |
| 2012-06-30 | 0.02 | $-383.42 | 0.00 |
| 2012-03-31 | 0.81 | $-397.13 | 0.00 |
| 2011-12-31 | 0.67 | $-408.61 | 0.00 |
| 2011-09-30 | 1.01 | $-419.34 | 0.00 |
| 2011-06-30 | 1.06 | $-447.01 | 0.00 |
| 2011-03-31 | 1.62 | $-415.50 | 0.00 |
| 2010-12-31 | 1.52 | $-392.72 | 0.00 |
| 2010-09-30 | 0.86 | $-535.68 | 0.00 |
| 2010-06-30 | 1.33 | $-539.47 | 0.00 |
| 2010-03-31 | 2.46 | $-641.28 | 0.00 |
| 2009-12-31 | 3.23 | $-650.04 | 0.00 |
| 2009-09-30 | 4.94 | $-964.20 | -0.01 |
| 2009-06-30 | 3.23 | $-895.84 | 0.00 |
| 2009-03-31 | 1.14 | $-626.72 | 0.00 |
| 2008-12-31 | 1.05 | $-590.21 | 0.00 |
| 2008-09-30 | 3.80 | $-663.22 | -0.01 |
| 2008-06-30 | 4.18 | $-619.88 | -0.01 |
| 2008-03-31 | 5.89 | $-542.74 | -0.01 |
| 2007-12-31 | 5.51 | $-620.81 | -0.01 |
| 2007-09-30 | 7.22 | $-692.16 | -0.01 |
| 2007-06-30 | 0.61 | $-708.39 | 0.00 |
| 2007-03-31 | 15.58 | $-677.91 | -0.02 |
| 2006-12-31 | 12.35 | $-688.08 | -0.02 |
| 2006-09-30 | 12.73 | $-584.21 | -0.02 |
| 2006-06-30 | 16.15 | $-726.78 | -0.02 |
| 2006-03-31 | 30.02 | $-702.83 | -0.04 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.010B | $0.000B |
| Ainos, Inc. has evolved from a niche biotechnology and medical diagnostics developer into a company pioneering a new category of artificial intelligence known as SmellTech or Smell AI. Centered on its flagship AI Nose platform, Ainos digitizes scent into machine-readable Smell ID data for intelligent sensing applications across robotics, smart manufacturing, semiconductors and healthcare infrastructure, while maintaining selective legacy therapeutic programs. Ainos is incorporated in Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.882B | 25.03 |
| CVS Health (CVS) | United States | $122.206B | 12.19 |
| HCA Healthcare (HCA) | United States | $92.119B | 14.32 |
| Elevance Health (ELV) | United States | $92.005B | 14.44 |
| Cencora (COR) | United States | $62.254B | 19.02 |
| Natera (NTRA) | United States | $49.267B | 0.00 |
| Labcorp Holdings (LH) | United States | $25.572B | 18.03 |
| Viatris (VTRS) | United States | $19.136B | 6.61 |
| Medpace Holdings (MEDP) | United States | $16.619B | 34.90 |
| DiDi Global (DIDIY) | China | $16.275B | 178.51 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.114B | 0.00 |
| Solventum (SOLV) | United States | $15.290B | 12.65 |
| Revvity (RVTY) | United States | $14.338B | 24.02 |
| Charles River Laboratories (CRL) | United States | $13.038B | 27.59 |
| ICON (ICLR) | Ireland | $12.935B | 17.58 |
| BrightSpring Health Services (BTSG) | United States | $11.931B | 41.02 |
| Avantor (AVTR) | United States | $10.254B | 18.49 |
| BioMerieux (BMXMF) | France | $10.192B | 0.00 |
| HealthEquity (HQY) | United States | $7.944B | 25.89 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.362B | 72.36 |
| PACS (PACS) | United States | $7.051B | 23.70 |
| Sonic Healthcare (SKHHY) | Australia | $6.687B | 0.00 |
| GETINGE (GNGBY) | Sweden | $6.654B | 18.79 |
| CochLear (CHEOY) | Australia | $6.355B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.282B | 23.76 |
| MiniMed (MMED) | United States | $6.181B | 0.00 |
| Sotera Health (SHC) | United States | $5.285B | 21.79 |
| Concentras Parent (CON) | United States | $4.566B | 22.52 |
| Organon (OGN) | United States | $3.585B | 4.55 |
| CareDx (CDNA) | United States | $2.709B | 308.06 |
| Alignment Healthcare (ALHC) | United States | $2.684B | 68.11 |
| GeneDx Holdings (WGS) | United States | $2.676B | 249.28 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.187B | 12.81 |
| Establishment Labs Holdings (ESTA) | United States | $2.143B | 0.00 |
| Progyny (PGNY) | United States | $2.137B | 30.27 |
| COMPASS Pathways (CMPS) | United Kingdom | $2.013B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.914B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.838B | 70.20 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $1.695B | 10.18 |
| Freenome (FRNM) | United States | $1.607B | 0.00 |
| Ardent Health (ARDT) | United States | $1.552B | 8.87 |
| Agilon Health (AGL) | United States | $1.551B | 0.00 |
| Nutex Health (NUTX) | United States | $1.486B | 8.52 |
| InnovAge Holding (INNV) | United States | $1.470B | 0.00 |
| Omada Health (OMDA) | United States | $1.255B | 256.25 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.220B | 23.73 |
| Teladoc Health (TDOC) | United States | $1.181B | 0.00 |
| CryoPort (CYRX) | United States | $0.808B | 0.00 |
| GMR Solutions (GMRS) | United States | $0.716B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Forward Industries (FWDI) | United States | $0.513B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.474B | 0.00 |
| SBC Medicals (SBC) | United States | $0.467B | 9.66 |
| Shoulder Innovations (SI) | United States | $0.382B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.377B | 5.47 |
| Embecta (EMBC) | United States | $0.297B | 2.57 |
| Biodesix (BDSX) | United States | $0.289B | 0.00 |
| So-Young (SY) | China | $0.266B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.109B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.101B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.091B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.079B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.065B | 7.65 |
| Tevogen (TVGN) | United States | $0.049B | 0.00 |
| DocGo (DCGO) | United States | $0.037B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.014B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |